UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review

International journal of molecular sciences, 2022-04, Vol.23 (7), p.3995

2022

Link zum Volltext

Verfügbarkeit prüfen

Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard

Journal of medical Internet research, 2024-05, Vol.26 (5), p.e54758-e54758

2024

Link zum Volltext

Verfügbarkeit prüfen

The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer

International journal of molecular sciences, 2022-08, Vol.23 (15), p.8535

2022

Link zum Volltext

Verfügbarkeit prüfen

Applications of large language models in cancer care: current evidence and future perspectives

Frontiers in oncology, 2023-09, Vol.13, p.1268915-1268915

2023

Link zum Volltext

Verfügbarkeit prüfen

Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma

Cancers, 2023-01, Vol.15 (2), p.529

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Inhibitors as a Threat to the Hypothalamus-Pituitary Axis: A Completed Puzzle

Cancers, 2022-02, Vol.14 (4), p.1057

2022

Link zum Volltext

Verfügbarkeit prüfen

Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives

Journal of personalized medicine, 2023-08, Vol.13 (9), p.1339

2023

Link zum Volltext

Verfügbarkeit prüfen

Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task

Frontiers in endocrinology (Lausanne), 2022-03, Vol.13, p.840971-840971

2022

Link zum Volltext

Verfügbarkeit prüfen

Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic

Cancers, 2022-01, Vol.14 (3), p.593

2022

Link zum Volltext

Verfügbarkeit prüfen

NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series

Journal of personalized medicine, 2022-11, Vol.12 (11), p.1819

2022

Link zum Volltext

Verfügbarkeit prüfen

Secondary cytoreduction for relapsed ovarian cancer

The lancet oncology, 2021-06, Vol.22 (6), p.e232-e232

2021

Link zum Volltext

Verfügbarkeit prüfen

A scoping review on the “burned out” or “burnt out” testicular cancer: When a rare phenomenon deserves more attention

Critical reviews in oncology/hematology, 2021-09, Vol.165, p.103452-103452, Article 103452

2021

Link zum Volltext

Verfügbarkeit prüfen

The value of IMmotion010 for rare kidney cancer histologies

The Lancet (British edition), 2023-07, Vol.402 (10397), p.181-181

2023

Link zum Volltext

Verfügbarkeit prüfen

Older adults (OA) in clinical trials: Where are they? Representation of OA in clinical trials conducted at the national cancer institute (NCI) clinical center

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18517-e18517

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study

The oncologist (Dayton, Ohio), 2024-05, Vol.29 (5), p.407-414

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials

Cancer treatment reviews, 2023-11, Vol.120, p.102623-102623, Article 102623

2023

Link zum Volltext

Verfügbarkeit prüfen

Mismatch repair deficiency and microsatellite instability-high in urothelial carcinoma: A systematic review and meta-analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4570-4570

2023

Link zum Volltext

Verfügbarkeit prüfen

1199 Efficacy of bevacizumab versus PARP inhibitors as maintenance therapy after first-line platinum-based chemotherapy for homologous recombination proficient, advanced high-grade ovarian cancer patients: a retrospective study

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A407-A408

2024

Link zum Volltext

Verfügbarkeit prüfen

Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab

Oncology, 2017-01, Vol.93 (1), p.62-66

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of bintrafusp alfa and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic genitourinary (GU) malignancies

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4571-4571

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib + nivolumab +/- ipilimumab

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16506-e16506

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS4607-TPS4607

2023

Link zum Volltext

Verfügbarkeit prüfen

Gastric Immune Prognostic Index (GIPI) in metastatic (m) gastro-oesophageal junction (GOJ)/gastric cancer (GC) patients (pts) treated with PD-1/PD-L1 immune checkpoint inhibitors (ICIs)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.417-417

2020

Link zum Volltext

Verfügbarkeit prüfen

Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis

BMJ Oncology, 2024-05, Vol.3 (1)

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review

Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard

The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Applications of large language models in cancer care: current evidence and future perspectives

Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma

Immune Checkpoint Inhibitors as a Threat to the Hypothalamus-Pituitary Axis: A Completed Puzzle

Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives

Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task

Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic

NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series

Secondary cytoreduction for relapsed ovarian cancer

A scoping review on the “burned out” or “burnt out” testicular cancer: When a rare phenomenon deserves more attention

The value of IMmotion010 for rare kidney cancer histologies

Older adults (OA) in clinical trials: Where are they? Representation of OA in clinical trials conducted at the national cancer institute (NCI) clinical center

Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study

Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials

Mismatch repair deficiency and microsatellite instability-high in urothelial carcinoma: A systematic review and meta-analysis

1199 Efficacy of bevacizumab versus PARP inhibitors as maintenance therapy after first-line platinum-based chemotherapy for homologous recombination proficient, advanced high-grade ovarian cancer patients: a retrospective study

Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab

A phase I study of bintrafusp alfa and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic genitourinary (GU) malignancies

Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib + nivolumab +/- ipilimumab

A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects

Gastric Immune Prognostic Index (GIPI) in metastatic (m) gastro-oesophageal junction (GOJ)/gastric cancer (GC) patients (pts) treated with PD-1/PD-L1 immune checkpoint inhibitors (ICIs)

Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis

Suchergebnisse filtern